Statistics on Medically Eligible Pregnant Women who Received mRNA Vaccination and Side Effects Observed

Dr Tan Wu Meng asked the Minister for Health (a) to date, how many and what proportion of medically eligible pregnant women in Singapore have received an mRNA vaccination against COVID-19; (b) what are the types and frequencies of side effects that have been observed so far; and (c) how does this compare with the experience of other countries.

The Health Sciences Authority (HSA) has received a small number of non-serious adverse event (AE) reports with the Pfizer-BioNTech/Comirnaty vaccine in pregnant women. These include rash, syncope (fainting), dizziness and one report of Bell’s Palsy (temporary weakness of the facial muscles). These AEs are similar to those reported in the general population.

There is currently no evidence of safety concerns when mRNA vaccines are used in pregnant women, based on real-world clinical data. MOH and HSA will continue to monitor both the local and international safety data.